New GMFH “best of” document outlines the latest research on gut microbiota & early life
Many of the processes through which microbial exposures facilitate immune system development remain to be identified." Marie-Claire Arrieta.
“Gut microbial colonization during early life influences human development by triggering age-dependent immune mechanisms. Although considerable research effort has been made to understand microbial influences on health in early life, many of the processes through which microbial exposures facilitate immune system development remain to be identified.” (Prof. Marie-Claire Arrieta)
The GMFH publishing team is pleased to share a new summary document—this one on the latest scientific work on gut microbiota in early life. With an editorial from Prof. Marie-Claire Arrieta, Assistant Professor in the Department of Physiology & Pharmacology and the Department of Paediatrics at the Cumming School of Medicine at the University of Calgary (Canada), this document contains a selection of key scientific studies related to babies and gut microbes, plus a list of resources for further reading.
The GMFH team will continue to keep you updated on this exciting topic—check our website regularly or subscribe to our twice-monthly newsletter!
Gut Microbiota & Early Life “Best of”
GMFH Editing Team
GMFH Editing Team
Studies over the last decade have brought new hope that gut microbiome-targeted therapeutics might offer novel treatments for obesity. In this post, we ask whether dietary interventions, prebiotics, probiotics and medication that target the microbiome are useful for weight management.
The 11th Gut Microbiota for Health World Summit focused on emerging gut microbiome-targeted treatments in digestive, immune and cardiometabolic health. This post highlights the major take-aways from the conference and explores how they might impact clinical practice in the foreseeable future.
Following the GMFH 2022 Year at a Glance report, it is time for a flashback in the latest research on cancer microbiome. This post ranges between the epidemiology, etiology and diagnosis of cancer, looking at the role of fungal and bacterial gut microbiome in all three health care branches.